Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:30:02 03/07/2024 am IST			5-day change	1st Jan Change
229.2 ^USD	-0.01%		-1.98%	-5.98%

01:57pm	Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating	MT
26/06	BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool	CI

BD (Becton, Dickinson and Company) Declares Quarterly Dividend, Payable on March 31, 2023

January 25, 2023 at 02:45 am IST

The Board of Directors of BD (Becton, Dickinson and Company) has declared a quarterly dividend of $0.91 per common share, payable on March 31, 2023 to holders of record on March 10, 2023. The indicated annual dividend rate is $3.64 per share.

Latest news about Becton, Dickinson and Company

Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating	05:27pm	MT
BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool	26/06	CI
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024	20/06	CI
Evercore ISI Raises Becton, Dickinson and Company's Price Target to $290 From $282	14/06	MT
Sector Update: Health Care Stocks Steady Premarket Monday	03/06	MT
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash	03/06	DJ
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03/06	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03/06	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03/06	MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03/06	CI
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300	15/05	MT
Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	14/05
Exclusive-Biden to put tariffs on China medical supplies - sources	10/05	RE
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating	06/05	MT
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271	03/05	MT
Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280	02/05	MT
Sector Update: Health Care Stocks Mixed Premarket Thursday	02/05	MT
Sector Update: Health Care	02/05	MT
Transcript : Becton, Dickinson and Company, Q2 2024 Earnings Call, May 02, 2024	02/05
Becton, Dickinson's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised	02/05	MT
Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings	02/05	DJ
(BDX) BD (BECTON DICKINSON AND COMPANY) Expects Fiscal Year 2024 EPS Range $12.95 - $13.15	02/05	MT
Earnings Flash (BDX) BD (BECTON DICKINSON AND COMPANY) Reports Q2 Revenue $5.05B, vs. Street Est of $5.04B	02/05	MT
Earnings Flash (BDX) BD (BECTON DICKINSON AND COMPANY) Posts Q2 EPS $3.17, vs. Street Est of $2.97	02/05	MT
Becton, Dickinson and Company Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	02/05	CI

Chart Becton, Dickinson and Company

Duration

Period

More charts

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

01/08/2024 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Becton, Dickinson and Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

229.3 USD

Average target price

278.9 USD

Spread / Average Target

+21.64%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BECTON, DICKINSON AND COMPANY	-5.98%	66.26B
ABBOTT LABORATORIES	-6.24%	180B
MEDTRONIC PLC	-6.08%	98.89B
DEXCOM, INC.	-9.35%	44.61B
CENCORA, INC.	+8.34%	44.02B
HOYA CORPORATION	+10.13%	40.12B
METTLER-TOLEDO INTERNATIONAL, INC.	+11.88%	29.19B
WEST PHARMACEUTICAL SERVICES, INC.	-8.38%	23.64B
TERUMO CORPORATION	+13.33%	23.41B
ZIMMER BIOMET HOLDINGS, INC.	-12.68%	21.8B

Other Medical Equipment, Supplies & Distribution